Company Search:
Advanced Search
Sponsored Links
UBI Pharma Inc Company Snapshot
UBI Pharma Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares UBI Pharma Inc with three other companies in this sector in Taiwan: Johnson Chemical Pharmaceutical Works Co Ltd (2018 sales of 411.91 million Taiwanese Dollars [US$13.77 million] ), Genovate Biotechnology Co., Limited (455.80 million Taiwanese Dollars [US$15.24 million] of which 94% was Medicine Manufacturing), and Sagittarius Life Science Corp. (411.41 million Taiwanese Dollars [US$13.75 million] of which 96% was Non-toxic sector).

Sales Analysis.
  Stock Performance Chart for UBI Pharma Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/1/2019): 6.46
(Figures in Taiwanese Dollars)
1 Week 1.7%   13 Weeks -48.2%  
4 Weeks -53.9%   52 Weeks -45.1%  
UBI Pharma Inc Key Data:
  Ticker: 6562 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 423,863,000
(Year Ending Jan 2019).
Employees: N/A
  Currency: Taiwanese Dollars Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: GU Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.